Literature DB >> 1104227

IgG subclasses of fluorescent treponemal antibodies: correlation with complement fixation and clinical stage.

E M Puritz, J A Thompson, F Dierberg, S J Kraus, W J Yount.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1104227     DOI: 10.1016/0090-1229(75)90004-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  7 in total

1.  Anti-Treponema pallidum IgM, IgA, and IgG subclass antibody responses after treatment in patients with syphilis at various stages: 1. Assessments by enzyme-linked immunosorbent assay.

Authors:  S Tanaka; T Suzuki
Journal:  Genitourin Med       Date:  1990-06

2.  Problems affecting performance of the fluorescent treponemal antibody-absorption test for syphilis.

Authors:  E F Hunter; M R Adams; L H Orrison; B J Pender; S A Larsen
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

3.  Immunoglobulin specificity for the fluorescent treponemal antibody-absorption test conjugate.

Authors:  E F Hunter; S E Maddison; S A Larsen; M B Felker; J C Feeley
Journal:  J Clin Microbiol       Date:  1976-10       Impact factor: 5.948

4.  Uneven distribution of antitreponema antibody acitivity in differing immunoglobulin G fractions from patients with early syphilis.

Authors:  J J van der Sluis; M Boer
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

5.  Immunoglobulin G subclasses of fluorescent anti-Treponema pallidum antibodies: evidence for sequential development of specific anti-T. pallidum immunoglobulin G responses in patients with early syphilis.

Authors:  J J van der Sluis; E C van Reede; M Boer
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Ig class and IgG subclass responses to Treponema pallidum in patients with syphilis.

Authors:  R E Baughn; J L Jorizzo; C B Adams; D M Musher
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

7.  Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.

Authors:  R A Eisenberg; K Dyer; S Y Craven; C R Fuller; W J Yount
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.